European regulatory experience with drugs for central nervous system disorders

Butlen-Ducuing and colleagues analyse ~20 years of data on regulatory applications assesssed by the European Medicines Agency in psychiatry and neurology, with the aim of illuminating challenges that underlie the 'pipeline problem' for drugs for central nervous system disorders.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Drug discovery 2015-02, Vol.14 (2), p.89-90
Hauptverfasser: Butlen-Ducuing, Florence, Zienowicz, Malgorzata, Pétavy, Frank, Haas, Manuel, Salmonson, Tomas, Eichler, Hans-Georg, Rasi, Guido
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Butlen-Ducuing and colleagues analyse ~20 years of data on regulatory applications assesssed by the European Medicines Agency in psychiatry and neurology, with the aim of illuminating challenges that underlie the 'pipeline problem' for drugs for central nervous system disorders.
ISSN:1474-1776
1474-1784
DOI:10.1038/nrd4511